Algemeen nieuws

Onderzoek naar hersenaneurysma’s krijgt ICRPA-financiering

Onderzoek naar hersenaneurysma’s richt zich op betere inzicht van barsten voor betere voorspelling en ontwikkeling van veiligere behandeling.

UMC Utrecht neemt derde operatierobot in gebruik

UMC Utrecht heeft een derde operatierobot in gebruik genomen. Met de komst van de nieuwste generatie, de Da Vinci 5, kunnen nog meer patiënten minimaal belastend worden geopereerd. Dat leidt tot minder complicaties en een sneller herstel.

Trage keuze over Spinraza hinderde kinderen met SMA

De BedBieb brengt verhalen naar onze patiënten in het WKZ

Met deze rijdende bibliotheek kunnen onze jonge patiënten vanuit hun bed nieuwe boeken lezen of worden voorgelezen.

Brein blijkt veel zachter dan gedacht

Sterker nog: het brein gedraagt zich bijna als een vloeistof.

UMC Utrecht leidt twee grote AI-projecten voor betere zorg

Histotripsie en immuuntherapie: eerste resultaten iFOCUS

UMC Utrecht combineert histotripsie met immuuntherapie bij uitgezaaide kanker.

Zijn mijn patiëntgegevens nog wel veilig?

Softwareleverancier UMC Utrecht slachtoffer van hack

Roderick Venekamp benoemd tot hoogleraar Infectieziekten in de eerstelijnszorg

Snelle afweertest helpt complicaties na trauma te voorkomen

Snelle immuundiagnostiek helpt het afweersysteem te monitoren en kan complicaties na trauma- en zware operaties helpen voorkomen.

Zorg onder druk vraagt om verbinden, leren en kiezen

Nijntje verwelkomt jongvolwassenen in het UMC Utrecht

Study of new treatment for severe influenza pneumonia

Van elke vijf patiënten die met ernstige longontsteking door influenza op de intensive care (IC) worden opgenomen, overlijdt er gemiddeld één. Om dit relatief hoge risico op overlijden te verlagen, gaan Nederlandse onderzoekers onder leiding van UMC Utrecht geneesmiddelen die eerder succesvol waren bij de behandeling van patiënten met ernstige Covid-19 op de IC terecht kwamen, nu ook onderzoeken bij IC-patiënten met ernstige longontsteking door influenza. ZonMw heeft voor deze studie een subsidie van ruim € 2.1 miljoen beschikbaar gesteld.

Assumption about cause DNA damage debunked

Worldwide, many supplements containing antioxidants, such as vitamins C and E, are being sold. These supplements would prevent cancer and ageing. New research from UMC Utrecht calls the rationale behind the protective role of antioxidants into question, putting the use of supplements with high doses of antioxidants in a different light.

European study to integrate palliative care in heart failure

Led by UMC Utrecht, a study on improving palliative care in heart failure has begun. The aim of the study is to integrate a palliative care approach into standard care for patients with heart failure and their loved ones in Europe. By responding faster and better to all the care needs of each individual patient, patients' quality of life will improve. Nine European countries are participating in the study, and the study will run for five years.

Gönül Dilaver appointed professor of Inclusive Higher Education

Dr. Gönül Dilaver, currently Biomedical Sciences program director at UMC Utrecht, has been appointed professor of Inclusive Higher Education. This appointment, effective April 1, 2024, marks an important moment in efforts to make education at Utrecht University and UMC Utrecht more accessible and inclusive. Over the years, Dilaver has championed the connection between science, society and inclusion in higher education.

Sabine Fuchs appointed professor

How do we improve care for patients with rare diseases for which there are currently no treatments? This question is central to the work of pediatrician Sabine Fuchs. She has been appointed professor of Metabolic diseases and innovative therapies at the UMC Utrecht as of April 15, 2024. ‘I want to make these types of diseases treatable by also focusing on the other organs.’

"The Next Step"... Jeanette Leusen's inaugural lecture

On Tuesday, April 9, 2024, Jeanette Leusen, professor of Antibody Therapy at Utrecht University and UMC Utrecht, delivered her inaugural lecture. There she addressed the discovery, development and clinical application of antibodies. Partly due to the research of Jeanette and her group, antibodies based on immunoglobulin A (IgA) also appear to have great potential as a next generation treatment option in cancer, and perhaps also in infectious diseases. A first drug candidate is now ready for the next step: a ‘first-in-human’ study, but this will require more investment.

Can Jos Malda crack the code of cartilage?

In our aging society, healing joint problems is becoming increasingly important. To do this, cartilage damage must become repairable. But so far it has proven impossible to recreate the intricate internal structure of cartilage. Professor Jos Malda has now received an ERC Advanced grant of €2.5 million to crack that code.

Decoding the brain - Loss of use does not mean loss of function

Imagine you are completely immobile, only able to blink to communicate with the outside world. This is the reality for people with locked-in syndrome, a condition where patients are completely paralysed except for their eyes, while being fully conscious. Mark Bruurmijn spent his PhD working on building a brain-computer interface, helping these patients to communicate. On April 11th Bruurmijn receives his doctorate for his work on decoding the brain.

"I'm a real tech guy"

How do diseases develop? How can we recognize them more quickly? And how can we treat them in a more targeted way? By analyzing very large amounts of molecular data with the latest developments in artificial intelligence (AI). This is what Jeroen de Ridder is dedicated to. As of 1 April 2024, he has been appointed as professor of bioinformatics in molecular biology at UMC Utrecht, within the Strategic Program Cancer.

Grant for research teams UMC Utrecht from ZonMw Open Competition

Five research teams of the UMC Utrecht receive a grant for projects in the framework of the ZonMw Open Competition. With this funding, the research teams can develop innovative team science initiatives that contribute to innovation within fundamental (bio)medical science and long-term health care. Within all projects, the research teams collaborate with other knowledge institutions. A total of 29 projects were honored for an amount of 23 million euros.